Genetic Predisposition to Disease
0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
GenomicsNest Platform
Human BioSciencesGenome Sequencing
Helix BiopharmaExome sequencing
Clinical Trials (3)
Total enrollment: 2,000,680 patients across 3 trials
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Start: May 2023Est. completion: Nov 202640 patients
N/AActive Not Recruiting
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
Start: Dec 2022Est. completion: Oct 2027640 patients
N/AActive Not Recruiting
Helix Research Network
Start: Sep 2021Est. completion: Sep 20362,000,000 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 2,000,680 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.